A safety study of combination treatment with Avonex [interferon beta-1a] and Zocor [simvastatin] in relapsing remitting multiple sclerosis

Trial Profile

A safety study of combination treatment with Avonex [interferon beta-1a] and Zocor [simvastatin] in relapsing remitting multiple sclerosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Interferon beta-1a (Primary) ; Simvastatin
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top